Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 26Pain, Postoperative 17Neoplasms 13Lung Neoplasms 12Brain Neoplasms 12Depression 7Carcinoma, Hepatocellular 7Pain 6Colonic Neoplasms 6Thyroid Neoplasms 5Stomach Neoplasms 5Prostatic Neoplasms 5Leiomyoma 5Head and Neck Neoplasms 5Agnosia 5Ovarian Neoplasms 4Multiple Myeloma 4Delirium 4Colorectal Neoplasms 4Anxiety Disorders 4Supratentorial Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Myofibroma 3Lymphoma 3Hemorrhage 3Fatigue 3Emergence Delirium 3Chronic Pain 3Carcinoma, Non-Small-Cell Lung 3

Interventions

3-Iodobenzylguanidine 8anlotinib 4Temozolomide 4lutetium Lu 177 dotatate 3Phenoxybenzamine 3Everolimus 3pegfilgrastim 2cabozantinib 2Granulocyte Colony-Stimulating Factor 2Doxazosin 2Dexmedetomidine 2Capecitabine 2Adrenalectomy 23-fluorobenzylguanidine 2177Lu-octreotide, DOTA(0)-Tyr(3)- 2veliparib 1vatalanib 1vandetanib 1temsirolimus 1pentetreotide 1penpulimab 1pembrolizumab 1olaparib 1lenvatinib 1lanreotide 1gallium Ga 68 dotatate 1fluorodopa F 18 1fludarabine phosphate 1belzutifan 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pheochromocytoma × Saline Solution × Clear all
NCT06037135 2023-10-06

Dexmedetomidine Infusion During Laparoscopic Adrenalectomy

Yonsei University

Phase NA Completed
40 enrolled
Endocrine

Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡